Back
Aclaris Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
73
ACRS
Aclaris Therapeutics
Last Price:
2.56
Seasonality Move:
32.55%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.28 | Buy |
| 20-day SMA: | 1.74 | Buy |
| 50-day SMA: | 1.4 | Buy |
| 200-day SMA: | 1.26 | Buy |
| 8-day EMA: | 2.3 | Buy |
| 20-day EMA: | 1.9 | Buy |
| 50-day EMA: | 1.56 | Buy |
| 200-day EMA: | 1.92 | Buy |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 91.77 | Buy |
| Chaikin Money Flow: | 1458837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.12 - 2.14) | Buy |
| Bollinger Bands (100): | (1 - 1.64) | Buy |
Aclaris Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 2.63 while ACRS 8-day simple moving average is 2.28, which is a Buy signal.
- The stock price of ACRS is 2.63 while Aclaris Therapeutics 20-day SMA is 1.74, which makes it a Buy.
- Aclaris Therapeutics 50-day simple moving average is 1.40 while ACRS share price is 2.63, making it a Buy technically.
- ACRS stock price is 2.63 and Aclaris Therapeutics 200-day simple moving average is 1.26, creating a Buy signal.
ACRS Technical Analysis vs Fundamental Analysis
Buy
73
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Buy
The current Aclaris Therapeutics [ACRS] share price is $2.63. The Score for ACRS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
187.64M
Price in USD:
2.63
Share Volume:
1.76M
Aclaris Therapeutics 52-Week Range
52-Week High:
2.68
52-Week Low:
0.59
Buy
73
Aclaris Therapeutics (ACRS)
is a Buy
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 2.63 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is not overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 2.63 while ACRS 8-day exponential moving average is 2.30, which is a Buy signal.
- The stock price of ACRS is 2.63 while Aclaris Therapeutics 20-day EMA is 1.90, which makes it a Buy.
- Aclaris Therapeutics 50-day exponential moving average is 1.56 while ACRS share price is 2.63, making it a Buy technically.
- ACRS stock price is 2.63 and Aclaris Therapeutics 200-day simple moving average is 1.92, creating a Buy signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and an increase next year of $0.06 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Aclaris Therapeutics is a Buy
- Aclaris Therapeutics Relative Strength Index (RSI) is 91.77, which suggest Aclaris Therapeutics is overbought
- The Bollinger Bands (25) for Aclaris Therapeutics is (1.12 - 2.14), which suggest Aclaris Therapeutics is a Buy
- The Bollinger Bands (100) for Aclaris Therapeutics is (1 - 1.64), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.